Abstract
Infection continues to be the foremost cause of morbidity and mortality in patients undergoing antineoplastic chemotherapy. Despite improved diagnostic tools, better understanding of infectious etiologies, and the advent of several new antimicrobials, infections continue to be a major problem [1]. Cancer patients suffer from host immune system defects and anatomic barrier disruption that predispose them to infections. Understanding the different risk factors in the individual patient is necessary to implement the appropriate preventive strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bodey GP. Managing infections in the immunocompromised patient. Clin Infect Dis. 2005;40 Suppl 4:S239.
Gea-Banacloche JC, Palmore T, Walsh TJ, Holland SM, Segal BH. Infections in the cancer patient. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Principles & practice of oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 2569–616.
Young JH, Weisdorf DJ. Clinical approach to infections in the compromised host. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, et al., editors. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 2009. p. 1243–88.
Larson EL. APIC guideline for hand washing and hand antisepsis in health care settings. Am J Infect Control. 1995;23:251–69.
Vusirikala M. Supportive care in hematologic malignancies. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, et al., editors. Wintrobe’s clinical hematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 1747–90.
DeMille D, Deming P, Lupinacci P, et al. The effect of the neutropenic diet in the outpatient setting: a pilot study. Oncol Nurs Forum. 2006;33:337–43.
Wilson BJ. Dietary recommendations for neutropenic patients. Semin Oncol Nurs. 2002;18:44–9.
Hahn T, Cummings KM, Michalek AM, et al. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2002;23:525–31.
Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987;316:1627–32.
De Pauw BE, Novakova IR, Ubachs E, et al. Co-trimoxazole in patients with haematological malignancies: a review of 10-years’ clinical experience. Curr Med Res Opin. 1988;11:64–72.
Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol. 1998;16:1179–87.
Imran H, Tlvejeh IM, Arndt CA, et al. Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials. Eur J Clin Microbiol Infect Dis. 2008;27:53–63.
Bow EJ, Laverdiere M, Lussier N, et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer. 2002;94:3230–46.
Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized, placebo-controlled, double-blind, multicenter trial. Ann Intern Med. 1993;118:495–503.
Robenshtok E, Gafter-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007;25:5471–89.
Saral R, Ambinder RF, Burns WH, et al. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1983;99:773–6.
Selby PJ, Powles RL, Easton D, et al. The prophylactic role of intravenous and long term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer. 1989;59:434–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Garg, J., Sachdeva, A. (2014). Monitoring of High-Risk Areas: Cancer Wards. In: Wattal, C., Khardori, N. (eds) Hospital Infection Prevention. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1608-7_14
Download citation
DOI: https://doi.org/10.1007/978-81-322-1608-7_14
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1607-0
Online ISBN: 978-81-322-1608-7
eBook Packages: MedicineMedicine (R0)